UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 21, 2007
Xenomics, Inc.
(Exact name of registrant as specified in its charter)
|
Florida |
|
04-3721895 |
|
(State or other jurisdiction |
|
(IRS Employer |
|
of incorporation or organization) |
|
Identification No.) |
|
|
|
|
|
420 Lexington Avenue, Suite 1701 |
||
|
New York, New York 10170 |
||
|
(Address of principal executive offices) |
||
Registrant’s telephone number, including area code: (212) 297-0808
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On May 21, 2007, Xenomics, Inc. (the “Company”) and BSI Multihevetia (“BSI”) agreed to amend the warrant owned by BSI exercisable for 500,000 shares of common stock of the Company in order to extend the expiration date of such warrant to August 21, 2007 from June 21, 2007.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 25, 2007
|
XENOMICS, INC. |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Frederick Larcombe |
|
|
|
Frederick Larcombe |
|
|
|
|
Chief Financial Officer |
|
|
2